NVX vs CBAT

For growth investors, CBAK Energy Technology, Inc.

(CBAT) is the stronger pick with -13. 6% revenue growth year-over-year, versus -51. 8% for Novonix Limited (NVX). CBAK Energy Technology, Inc. (CBAT) offers the better valuation at 6. 1x trailing P/E, making it the more compelling value choice. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, CBAK Energy Technology, Inc.

(CBAT) delivered a total return of -78. 7%, compared to -96. 8% for Novonix Limited (NVX). Over 10 years, the gap is even starker: CBAT returned -69. 7% versus NVX's -96. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), CBAK Energy Technology, Inc.

(CBAT) is the lower-risk stock at 1. 01β versus Novonix Limited's 1. 89β — meaning NVX is approximately 88% more volatile than CBAT relative to the S&P 500. On balance sheet safety, CBAK Energy Technology, Inc. (CBAT) carries a lower debt/equity ratio of 25% versus 51% for Novonix Limited — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), CBAK Energy Technology, Inc.

(CBAT) is pulling ahead at -13. 6% versus -51. 8% for Novonix Limited (NVX). On earnings-per-share growth, the picture is similar: CBAK Energy Technology, Inc. grew EPS 574. 5% year-over-year, compared to -7. 1% for Novonix Limited. Over a 3-year CAGR, CBAT leads at 49. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

CBAK Energy Technology, Inc.

(CBAT) is the more profitable company, earning 6. 7% net margin versus -1278. 0% for Novonix Limited — meaning it keeps 6. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CBAT leads at 5. 0% versus -880. 0% for NVX. At the gross margin level — before operating expenses — NVX leads at 69. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, CBAK Energy Technology, Inc.

(CBAT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 01)). Novonix Limited (NVX) carries a higher beta of 1. 89 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CBAT: -69. 7%, NVX: -96. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: NVX is a small-cap quality compounder stock; CBAT is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.